CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset

Overview

Journal Cell

Publisher Cell Press

Specialty Cell Biology

Date 2019 Aug 10

PMID 31398342

Citations 219

Affiliations

Soon will be listed here.

Abstract

Variable, glutamine-encoding, CAA interruptions indicate that a property of the uninterrupted HTT CAG repeat sequence, distinct from the length of huntingtin's polyglutamine segment, dictates the rate at which Huntington's disease (HD) develops. The timing of onset shows no significant association with HTT cis-eQTLs but is influenced, sometimes in a sex-specific manner, by polymorphic variation at multiple DNA maintenance genes, suggesting that the special onset-determining property of the uninterrupted CAG repeat is a propensity for length instability that leads to its somatic expansion. Additional naturally occurring genetic modifier loci, defined by GWAS, may influence HD pathogenesis through other mechanisms. These findings have profound implications for the pathogenesis of HD and other repeat diseases and question the fundamental premise that polyglutamine length determines the rate of pathogenesis in the "polyglutamine disorders."

Citing Articles

CellFIE: Integrating Pathway Discovery With Pooled Profiling of Perturbations Uncovers Pathways of Huntington's Disease, Including Genetic Modifiers of Neuronal Development and Morphology.

Kang B, Murphy M, Ng C, Leventhal M, Huynh N, Im E bioRxiv. 2025; .

PMID: 40027702 PMC: 11870572. DOI: 10.1101/2025.02.19.639023.

Advances in Huntington's Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review.

Aqel S, Ahmad J, Saleh I, Fathima A, Al Thani A, Mohamed W Biology (Basel). 2025; 14(2).

PMID: 40001897 PMC: 11852324. DOI: 10.3390/biology14020129.

Repeat expansion in a fragile X model is independent of double strand break repair mediated by Pol θ, RAD52, RAD54 or RAD54B.

Hayward B, Kim G, Miller C, McCann C, Lowery M, Wood R Sci Rep. 2025; 15(1):5033.

PMID: 39934227 PMC: 11814403. DOI: 10.1038/s41598-025-87541-3.

Accelerated epigenetic aging in Huntington's disease involves polycomb repressive complex 1.

Brule B, Alcala-Vida R, Penaud N, Scuto J, Mounier C, Seguin J Nat Commun. 2025; 16(1):1550.

PMID: 39934111 PMC: 11814324. DOI: 10.1038/s41467-025-56722-z.

Glutamine missense suppressor transfer RNAs inhibit polyglutamine aggregation.

Tennakoon R, Bily T, Hasan F, Syal S, Voigt A, Balci T Mol Ther Nucleic Acids. 2025; 36(1):102442.

PMID: 39897579 PMC: 11787650. DOI: 10.1016/j.omtn.2024.102442.

References

Zhou X, Stephens M . Genome-wide efficient mixed-model analysis for association studies. Nat Genet. 2012; 44(7):821-4. PMC: 3386377. DOI: 10.1038/ng.2310. View

Shi H, Kichaev G, Pasaniuc B . Contrasting the Genetic Architecture of 30 Complex Traits from Summary Association Data. Am J Hum Genet. 2016; 99(1):139-53. PMC: 5005444. DOI: 10.1016/j.ajhg.2016.05.013. View

Vaser R, Adusumalli S, Leng S, Sikic M, Ng P . SIFT missense predictions for genomes. Nat Protoc. 2015; 11(1):1-9. DOI: 10.1038/nprot.2015.123. View

Swami M, Hendricks A, Gillis T, Massood T, Mysore J, Myers R . Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset. Hum Mol Genet. 2009; 18(16):3039-47. PMC: 2714728. DOI: 10.1093/hmg/ddp242. View

Sathasivam K, Neueder A, Gipson T, Landles C, Benjamin A, Bondulich M . Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc Natl Acad Sci U S A. 2013; 110(6):2366-70. PMC: 3568346. DOI: 10.1073/pnas.1221891110. View

Lieberman A, Shakkottai V, Albin R . Polyglutamine Repeats in Neurodegenerative Diseases. Annu Rev Pathol. 2018; 14:1-27. PMC: 6387631. DOI: 10.1146/annurev-pathmechdis-012418-012857. View

. Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease. Cell. 2015; 162(3):516-26. PMC: 4524551. DOI: 10.1016/j.cell.2015.07.003. View

Gusev A, Ko A, Shi H, Bhatia G, Chung W, Penninx B . Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet. 2016; 48(3):245-52. PMC: 4767558. DOI: 10.1038/ng.3506. View

Dragileva E, Hendricks A, Teed A, Gillis T, Lopez E, Friedberg E . Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes. Neurobiol Dis. 2008; 33(1):37-47. PMC: 2811282. DOI: 10.1016/j.nbd.2008.09.014. View

10.

Bastarache L, Hughey J, Hebbring S, Marlo J, Zhao W, Ho W . Phenotype risk scores identify patients with unrecognized Mendelian disease patterns. Science. 2018; 359(6381):1233-1239. PMC: 5959723. DOI: 10.1126/science.aal4043. View

11.

de Leeuw C, Mooij J, Heskes T, Posthuma D . MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol. 2015; 11(4):e1004219. PMC: 4401657. DOI: 10.1371/journal.pcbi.1004219. View

12.

Eppig J, Blake J, Bult C, Kadin J, Richardson J . The Mouse Genome Database (MGD): facilitating mouse as a model for human biology and disease. Nucleic Acids Res. 2014; 43(Database issue):D726-36. PMC: 4384027. DOI: 10.1093/nar/gku967. View

13.

Lee J, Gillis T, Mysore J, Ramos E, Myers R, Hayden M . Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region. Am J Hum Genet. 2012; 90(3):434-44. PMC: 3309179. DOI: 10.1016/j.ajhg.2012.01.005. View

14.

Kennedy L, Evans E, Chen C, Craven L, Detloff P, Ennis M . Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis. Hum Mol Genet. 2003; 12(24):3359-67. DOI: 10.1093/hmg/ddg352. View

15.

Kosmicki J, Samocha K, Howrigan D, Sanders S, Slowikowski K, Lek M . Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples. Nat Genet. 2017; 49(4):504-510. PMC: 5496244. DOI: 10.1038/ng.3789. View

16.

McCarthy S, Das S, Kretzschmar W, Delaneau O, Wood A, Teumer A . A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet. 2016; 48(10):1279-83. PMC: 5388176. DOI: 10.1038/ng.3643. View

17.

Norremolle A, Budtz-Jorgensen E, Fenger K, Nielsen J, Sorensen S, Hasholt L . 4p16.3 haplotype modifying age at onset of Huntington disease. Clin Genet. 2009; 75(3):244-50. DOI: 10.1111/j.1399-0004.2008.01136.x. View

18.

Cohen R, Margolis R . Spinocerebellar ataxia type 12: clues to pathogenesis. Curr Opin Neurol. 2016; 29(6):735-742. DOI: 10.1097/WCO.0000000000000385. View

19.

Wheeler V, Auerbach W, White J, Srinidhi J, Auerbach A, Ryan A . Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. Hum Mol Genet. 1999; 8(1):115-22. DOI: 10.1093/hmg/8.1.115. View

20.

Howes T, Tomkinson A . DNA ligase I, the replicative DNA ligase. Subcell Biochem. 2012; 62:327-41. PMC: 3881551. DOI: 10.1007/978-94-007-4572-8_17. View